羥氯喹在SLE合并妊娠患者中應(yīng)用的療效和安全性評(píng)估
[Abstract]:Objective: To investigate the effect of hydroxychloroquine on disease activity, pregnancy outcome and fetal outcome in pregnant women with systemic lupus erythematosus.
Methods: the clinical data of 83 patients with SLE selective pregnancy treated in Xiangya Hospital from August 2003 to March 2014 were retrospectively analyzed. According to whether HCQ was used in pregnancy, it was divided into HCQ group and non HCQ group. The SLE activity rate, pregnancy outcome, fetal outcome were compared in the two groups of pregnancy, and the follow-up was carried out for the offspring, including the growth and development, whether there were newborns. Lupus and autoantibody test.
Results: in group HCQ, 4 of 43 cases of pregnancy had SLE activity, 19 had recurrent nephrosis in the history of lupus nephritis, 7 cases of pregnancy loss, 6 premature delivery, 7 premature rupture of membranes, 5 amniotic fluid, 3 neonates with congenital abnormality, 3 cases of intrauterine embarrassment, 2 growth restriction, 4 cases of low weight infants. SLE activity occurred in 19 cases of non HCQ group 40 patients. In the patients with the history of lupus nephritis, 6 patients had recurrence of kidney disease, 8 cases of pregnancy loss, 8 cases of premature birth, 7 cases of premature rupture of membranes, 3 cases of oligohydramnios, 1 cases of intrauterine distress, 1 cases of growth restriction, and 6 cases of.HCQ group of low weight infants and the recurrence rate of lupus nephritis were significantly lower than those in non HCQ group (P=0.013 and P=0.042). Two groups of pregnancy outcome, and no significant difference in fetal outcome were found. (P0.05) group.HCQ 36 example generation, 1 cases of neonatal lupus, 6 example generation of anti nuclear antibody titer, 1 cases of brain dysplasia death. Non HCQ group 32 example, 1 cases of neonatal lupus, 5 example of the generation of antinuclear antibody titer.
Conclusion: the use of HCQ during pregnancy can reduce the SLE activity rate and LN recurrence rate in SLE patients without increasing the risk of adverse pregnancy outcomes and the risk of adverse fetal outcomes.
【學(xué)位授予單位】:中南大學(xué)
【學(xué)位級(jí)別】:碩士
【學(xué)位授予年份】:2014
【分類號(hào)】:R714.25
【共引文獻(xiàn)】
相關(guān)期刊論文 前10條
1 全美盈;王丹華;;系統(tǒng)性紅斑狼瘡合并妊娠子代早產(chǎn)兒42例臨床分析[J];中國當(dāng)代兒科雜志;2013年12期
2 王燕;;羥氯喹治療系統(tǒng)性紅斑狼瘡療效觀察[J];大家健康(學(xué)術(shù)版);2013年21期
3 黃鳳鳳;趙梅晶;吳珠娜;蘇月卿;;52例妊娠合并系統(tǒng)性紅斑狼瘡孕期并發(fā)癥及妊娠結(jié)局分析[J];華南國防醫(yī)學(xué)雜志;2013年12期
4 劉揚(yáng);葉茂昌;;抗瘧藥羥氯喹在治療口腔扁平苔蘚中的作用研究[J];口腔醫(yī)學(xué);2014年02期
5 李群苑;張科;勞敏曦;練仕珍;劉奎賢;;甲氨蝶呤治療系統(tǒng)性紅斑狼瘡的臨床療效及安全性分析[J];吉林醫(yī)學(xué);2014年13期
6 胡健;黃厚斌;魏世輝;;羥氯喹性視網(wǎng)膜病變及其檢測[J];解放軍醫(yī)學(xué)院學(xué)報(bào);2014年11期
7 陳佳;何婭妮;;慢性腎臟病妊娠患者的藥物使用原則[J];臨床合理用藥雜志;2014年14期
8 李嘉欣;張卓莉;;51例系統(tǒng)性紅斑狼瘡患者妊娠結(jié)局[J];中華臨床免疫和變態(tài)反應(yīng)雜志;2014年02期
9 劉恩令;周玉秀;劉錚;;系統(tǒng)性紅斑狼瘡合并妊娠患者的妊娠結(jié)局及其影響因素[J];中國全科醫(yī)學(xué);2014年30期
10 郭娟;周煒;;通過慢病毒載體構(gòu)建SSA/Ro52穩(wěn)定基因沉默細(xì)胞系[J];中華臨床免疫和變態(tài)反應(yīng)雜志;2014年03期
相關(guān)碩士學(xué)位論文 前5條
1 沈明虹;系統(tǒng)性紅斑狼瘡妊娠時(shí)機(jī)選擇在改善妊娠結(jié)局中的意義[D];福建醫(yī)科大學(xué);2013年
2 曾芙蓉;系統(tǒng)性紅斑狼瘡合并代謝綜合征的臨床研究[D];暨南大學(xué);2013年
3 劉秀華;40例孕期初發(fā)系統(tǒng)性紅斑狼瘡患者的臨床研究[D];廣西醫(yī)科大學(xué);2014年
4 黃媛;抗SSA/Ro60表位抗體與相關(guān)結(jié)締組織病心臟QTc間期及常見臨床損害間關(guān)系的研究[D];安徽醫(yī)科大學(xué);2014年
5 雷永生;1032例狼瘡腎炎臨床病理分析[D];鄭州大學(xué);2014年
,本文編號(hào):2144651
本文鏈接:http://sikaile.net/yixuelunwen/fuchankeerkelunwen/2144651.html